Buprenorphine: bell-shaped dose-response curve for its antagonist effects.
about
Buprenorphine: a unique drug with complex pharmacologySystematic Review of Pharmacological Properties of the Oligodendrocyte LineageComparison of abuse, suspected suicidal intent, and fatalities related to the 7-day buprenorphine transdermal patch versus other opioid analgesics in the National Poison Data System.Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.Opioid antagonist effects of dezocine in opioid-dependent humans.Buprenorphine reduces alcohol drinking through activation of the nociceptin/orphanin FQ-NOP receptor systemOligodendrocyte responses to buprenorphine uncover novel and opposing roles of μ-opioid- and nociceptin/orphanin FQ receptors in cell development: implications for drug addiction treatment during pregnancyClinical efficacy of buprenorphine to minimize distress in MRL/lpr mice.A review of the studies using buprenorphine in cats.The present and future of opioid analgesics in small animal practice.Comparison of spinal block after intrathecal clonidine-bupivacaine, buprenorphine-bupivacaine and bupivacaine alone in lower limb surgeriesAntinociceptive effects of epidural buprenorphine or medetomidine, or the combination, in conscious cats.Buprederm, a new transdermal delivery system of buprenorphine: pharmacokinetic, efficacy and skin irritancy studies.Effects of sedation with dexmedetomidine and buprenorphine on echocardiographic variables, blood pressure and heart rate in healthy cats.
P2860
Q24642980-B2170AED-D776-45C4-AD77-B0696CE9938EQ26768210-6BAA98DF-ED30-4D2A-A0EC-636279B80E30Q31147169-660BA04F-E597-4574-9F14-B772F914F76EQ34320180-7AACC201-9785-472E-B8EC-8D68812475BEQ34398867-46B1FA9A-4A70-4E0C-B316-B7BAAA266AA7Q34561447-3DCDD56B-3109-4326-9A6F-A6C3D7DA41F1Q35552420-27AB5E27-D9F3-4239-9F3D-09F082281EB7Q36942913-019B26F0-CAF8-4185-9A7E-83CF539DD8A9Q38198132-9DCB8DDD-DFF4-4BF3-B5D3-42558A02E751Q38789121-801B1281-4329-431C-8389-27A020C84AF9Q39285913-72D6AF9A-30EC-4A41-9E43-DC750FA23261Q43276466-E12F2183-BED6-4282-A026-FDE3DAE9878CQ46781546-23721680-72EE-40C2-ABE3-BCE139F41EF2Q50526795-48724B22-6574-49E5-AA09-DC8E226BF04B
P2860
Buprenorphine: bell-shaped dose-response curve for its antagonist effects.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Buprenorphine: bell-shaped dose-response curve for its antagonist effects.
@en
Buprenorphine: bell-shaped dose-response curve for its antagonist effects.
@nl
type
label
Buprenorphine: bell-shaped dose-response curve for its antagonist effects.
@en
Buprenorphine: bell-shaped dose-response curve for its antagonist effects.
@nl
prefLabel
Buprenorphine: bell-shaped dose-response curve for its antagonist effects.
@en
Buprenorphine: bell-shaped dose-response curve for its antagonist effects.
@nl
P1433
P1476
Buprenorphine: bell-shaped dose-response curve for its antagonist effects.
@en
P2093
P304
P356
10.1016/0306-3623(91)90452-C
P577
1991-01-01T00:00:00Z